Delivery Order SPE2DB20D3103-SPE2DB21FP8H1

Award Date 8/10/21
Potential Completion Date 8/11/21
Potential Value $147K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of PREVNAR 13 syringes (0.5 mL) to the Defense Logistics Agency (DLA). The award, valued at $114,576.84, is a delivery order contract with a firm fixed price. The contract has a performance period ending on March 31, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,771.09 for the supply of PREVNAR 13 SYRINGE 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
The Defense Logistics Agency (DLA) awarded a $18,424.84 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of PREVNAR 13 syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a $41,257.07 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of PREVNAR 13 syringes (0.5 mL). This contract does not have a set-aside designation, indicating an open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs. The...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price type, valued at $97,293.00, for the supply of PREVNAR 13 syringes. The award has an ultimate completion date of August 11, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,950.25 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product, with an ultimate completion date of January 16, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,548.24 firm-fixed-price delivery order is for the supply of PREVNAR 13 syringes (0.5 mL) and has a completion date of May 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $38,318.20, is for the delivery of PREVNAR 13 syringes. This is a firm fixed-price delivery order contract with no set-aside designation, indicating an open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key supplier to various government agencies, particularly the DLA and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the procurement of PREVNAR 13 SYRINGE 0.5ML medical supplies. The contract, valued at $7,639.03, is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of PREVNAR 13 0.5ML syringes. The award, valued at $93,739.03, was made by the Defense Logistics Agency (DLA) on January 30, 2023, with an ultimate completion date of January 31, 2023. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FP8H1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $146,886.74 for the supply of PREVNAR 13 syringes. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This DO is one of many issued under that larger IDC contract, enabling the DLA to efficiently procure essential medical commodities for military and veteran healthcare needs.

Generated 2/27/25, 9:49 AM